江西汇仁药业股份有限公司
- Country
- Ownership
- -
- Established
- 2002-04-03
- Employees
- -
- Market Cap
- -
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
166
NMPA:166
Drug Approvals
Sildenafil Citrate Orodispersible Tablets
- Product Name
- 枸橼酸西地那非口崩片
- Approval Number
- 国药准字H20244673
- Approval Date
- Oct 15, 2024
NMPA
Paracetamol，Aminophenazone，Caffeine and Chlorphenamine Maleate Capsules
- Product Name
- 酚氨咖敏胶囊
- Approval Number
- 国药准字H36022141
- Approval Date
- Jul 4, 2024
NMPA
Compound Sulfamethoxagole Capsules
- Product Name
- 复方磺胺甲噁唑胶囊
- Approval Number
- 国药准字H36022026
- Approval Date
- Jul 4, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
Clinical Trials
No trials found
News
No news found